Bank of Baroda ended flat after sharp gains in the previous session.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
The S&P BSE Sensex ended 190 points up at 23,382.
Besides foreign flows, corporate earnings and US Federal Reserve chief Janet Yellen's testimony to the nation's legislature are also likely to impact investor sentiment.
The broader Nifty of National Stock Exchange scaled the 10,200 mark intra day before closing at 10,184.85, showing a sizeable gain of 38.30 points, or 0.38 per cent.
It's time for Indian generic companies to rethink their strategies.
The Sensex closed higher by 170 points at 26,128 and the Nifty rose 59 points to end at 7,943.
Telecom stocks fell after Mukesh Ambani extended Reliance Jio's free offers till March 2017.
Raising concern about over-dependence of Indian capital markets on foreign institutional investors, eminent banker Deepak Parekh has said that something needs to be done to change this pattern.
With global markets pushing ahead, enthused by strengthening US jobs market, and also due to prospects of European rate hike, Indian markets also continued the march ahead.
Investors will maintain a cautious stance.
Markets gained for the second straight session to kick-off the September F&O series on a robust note.
Pharma shares extended losses after the government's ban on combination drugs.
Sensex remained volatile through the day.
Nifty50 surged 87 points to end at 8,157, highest closing levels since Oct 29, 2015.
The local markets are expected to react to global triggers until the government announces the Union Budget.
The rupee fell to a two-year low of 64.84 against the US dollar.
Investors must be cautious and follow a prudent diversification strategy to mitigate against any risks in case of any unforeseen events.
Positive cues from the global market front aided the rally.
Govt bans brands with annual sales worth Rs 3,728 crore.
Additional levy to eat into Rs 6,000-crore income of top promoters
The 30-share Sensex ended higher by 177.46 points at 28,885.21 and the Nifty gained 63.90 points at 8,778.30.
Another year of strong performance by these export-oriented sectors likely as US economy revives and rupee is expected to be under pressure.
Rate-sensitive sectors like banks, auto and realty witnessed strong buying demand in trades today
.jpg)
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
Sun Pharma emerged as the star performer and closed 4.03 per cent up at Rs 675.45, while Cipla rallied 1.58 per cent to Rs 592.60.
Gains were led by index heavyweights Reliance Industries and Infosys.
The S&P BSE Sensex has rallied about 28 per cent in 2014, after formation of a stable government at the Centre.
.jpg)
In an hour-long chat on rediff.com on Friday, A K Prabhakar, senior VP and Head -- Equity Research (Retail), Anand Rathi Financial Services Ltd, discussed the best stocks to put the investors' money in.
Financials were the top losers while oil shares also declined amid weak crude oil prices.
Positive cues from Asian peers also uplifted the sentiment.
The breadth was neutral with 1,329 advances and 1,320 declines.
The higher rate cut by RBI is positive for rate-sensitive sectors in the medium to long term.
Markets finished lower for the sixth consecutive day as hopes of the Goods and Services tax (GST) bill being passed in the current session of the Parliament faded considerably.
Investors will remain cautious ahead of F&O expiry.
The BSE IT sector, however, failed to snap a three-day losing streak and closed around 0.14 per cent lower.
Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.
SBI, PNB, Bank of Baroda, Canara Bank, Dena Bank, Central Bank of India ended down 3%-12% each.
On the sectoral front, rate-sensitive sectors such as Bankex and Auto gained by 1% and 0.7% respectively while BSE Consumer Durables gained 1.4%.
Top gainers from the Sensex pack are Infosys, Cipla, NTPC, ITC and Lupin
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances